SCLXW · Insider Trading
Scilex Holding Company Warrant
Every open-market purchase and sale reported by SCLXW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Stephen Hoi Ma | CFO, COO and Secretary | Buy | +650,000 deriv. | — |
| 2026-04-20 | Henry Ji | Exec Chair, CEO and President | MIXED | +2,600,000 deriv. | — |
| 2025-12-30 | Scilex Holding Co | 10%+ Owner | Sell | −20,657,300 | −$12.77M |
| 2025-10-09 | Stephen Hoi Ma | CFO and COO | A | +60,000 deriv. | — |
| 2025-10-09 | Yue Alexander Wu | Director | A | +20,000 deriv. | — |
| 2025-10-09 | Jay Chun | Director | A | +20,000 deriv. | — |
| 2025-10-09 | Dorman Followwill | Director | A | +20,000 deriv. | — |
| 2025-10-09 | Henry Ji | CEO and President | A | +120,000 deriv. | — |
| 2025-01-23 | SCLX Stock Acquisition JV LLC | 10%+ Owner | J | −3,250,000 | — |
| 2025-01-17 | SCLX Stock Acquisition JV LLC | 10%+ Owner | J | −779,371 | — |
| 2025-01-06 | SCLX Stock Acquisition JV LLC | 10%+ Owner | J | −5,000,000 | — |
| 2024-12-18 | Jaisim Shah | See Remarks | Buy | +30,000 | +$13.80K |
| 2024-12-17 | Dorman Followwill | Director | A | +100,000 deriv. | — |
| 2024-12-17 | Yue Alexander Wu | Director | A | +100,000 deriv. | — |
| 2024-12-17 | Jay Chun | Director | A | +100,000 deriv. | — |
| 2024-10-31 | Henry Ji | Executive Chairperson | Buy | +8,888 | +$8.35K |
| 2024-10-29 | Jaisim Shah | See Remarks | Buy | +32,000 | +$31.67K |
| 2024-10-18 | Jay Chun | Director | Buy | +5,000 | +$4.75K |
| 2024-10-18 | David Lemus | Director | Buy | +2,000 | +$1.80K |
| 2024-10-18 | Yue Alexander Wu | Director | Buy | +20,000 | +$18.99K |
| 2024-10-18 | Henry Ji | Executive Chairperson | Buy | +10,000 | +$9.71K |
| 2024-10-18 | Dorman Followwill | Director | Buy | +1,000 | +$990 |
| 2024-10-17 | Jaisim Shah | See Remarks | Buy | +30,000 | +$29.75K |
| 2024-10-17 | Stephen Hoi Ma | Chief Financial Officer | Buy | +6,700 | +$6.50K |
| 2024-08-19 | Annu Navani | Director | A | +250,000 deriv. | — |
| 2024-06-26 | Dorman Followwill | Director | A | +100,000 deriv. | — |
| 2024-06-26 | Dorman Followwill | Director | M | +1,000 | +$1.37K |
| 2024-06-26 | David Lemus | Director | A | +100,000 deriv. | — |
| 2024-06-20 | Jay Chun | Director | M | +5,000 | +$7.05K |
| 2024-06-20 | Stephen Hoi Ma | Chief Financial Officer | M | +2,000 | +$2.82K |
| 2024-06-20 | Jaisim Shah | See Remarks | M | +14,000 | +$24.22K |
| 2024-06-20 | Yue Alexander Wu | Director | M | +5,000 | +$7.05K |
| 2024-06-18 | Henry Ji | Executive Chairperson | M | +6,000 | +$8.46K |
| 2024-06-14 | Jaisim Shah | See Remarks | M | +33,333 | +$47.00K |
| 2024-05-17 | Jaisim Shah | See Remarks | Buy | +140,000 | +$121.95K |
| 2024-05-17 | Stephen Hoi Ma | Chief Financial Officer | Buy | +14,140 | +$12.44K |
| 2024-05-17 | Henry Ji | Executive Chairperson | Buy | +50,000 | +$43.98K |
| 2024-05-17 | Jay Chun | Director | Buy | +57,500 | +$51.64K |
| 2023-10-05 | Stephen Hoi Ma | Chief Financial Officer | A | +150,000 deriv. | — |
| 2023-10-05 | Yue Alexander Wu | Director | A | +250,000 deriv. | — |
| 2023-10-05 | Jaisim Shah | See Remarks | A | +200,000 deriv. | — |
| 2023-10-05 | Henry Ji | Executive Chairperson | A | +200,000 deriv. | — |
| 2023-10-05 | Jay Chun | Director | A | +250,000 deriv. | — |
| 2023-09-25 | Sorrento Therapeutics, Inc. | 10%+ Owner | Sell | −60,068,585 | — |
| 2023-03-20 | Henry Ji | Executive Chairperson | J | +2,730 | +$23.48K |
| 2023-01-23 | Sorrento Therapeutics, Inc. | 10%+ Owner | J | −73,740,795 | — |
| 2023-01-17 | Jaisim Shah | See Remarks | A | +1,700,000 deriv. | — |
| 2023-01-17 | Laura Hamill | Director | A | +250,000 deriv. | — |
| 2023-01-17 | Tien-Li Lee | Director | A | +250,000 deriv. | — |
| 2023-01-17 | David Lemus | Director | A | +250,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Scilex Holding Co | 10%+ Owner | 261,413,544 | $12.70M |
| SCLX Stock Acquisition JV LLC | 10%+ Owner | 51,039,214 | $2.48M |
| Henry Ji | Exec Chair, CEO and President | 322,910 | $15.69K |
| Jaisim Shah | See Remarks | 295,215 | $14.35K |
| Jay Chun | Director | 112,511 | $5.47K |
| Yue Alexander Wu | Director | 25,000 | $1.22K |
| Stephen Hoi Ma | CFO, COO and Secretary | 22,840 | $1.11K |
| Dorman Followwill | Director | 2,300 | $112 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SCLXW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.